Neurodon
Business Services · Indiana, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9800 Connecticut Dr Ste A2-202, Crown Po...Phone Number
(219) 801-0143Website
www.neurodon.netRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Neurodon
Neurodon is focused on revolutionizing medicine by targeting cellular stress, which is a root cause of various diseases. The company develops disease-modifying therapeutics aimed at normalizing calcium transport in cells, specifically through the activation of the SERCA enzyme. Their research addresses conditions such as diabetes, Alzheimer's, Parkinson's, and Duchenne muscular dystrophy by relieving endoplasmic reticulum stress. Neurodon's proprietary small molecules are designed to promote cellular health and improve patient outcomes.Explore more
Neurodon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neurodon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Neurodon
Check if Neurodon has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Neurodon has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Neurodon recently announced quarterly report
Product Launch: Get notified when Neurodon launches new products
Click to see if Neurodon had a recent Job posting/layoffs
Check out if Neurodon is spiking on competitors!
Neurodon, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Neurodon
Find 3 more new buyers
Compare Similar Companies to Neurodon
Compare insights from companies similar to Neurodon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Neurodon is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Neurodon is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Neurodon.
Neurodon Tech Stack
A closer look at the technologies used by Neurodon
Neurodon News & Media
Neurodon Awarded Nearly $3 Million from NIH to Advance its Drug for Alzheimer's Disease
CROWN POINT, Ind., Oct. 3, 2023 /PRNewswire/ -- Neurodon, a pharmaceutical company focused on the discovery and development of novel therapies for neurodegeneration, diabetes, and rare disease, announced today that it has been awarded approximately $2.9 million in continued funding under...Curative Potential for Diabetes, Alzheimer’s and Parkinson’s Seen in Research Data Highlighted at Neurodon’s 2nd Annual Scientific Advisory Board Meeting
CROWN POINT, Ind.--(BUSINESS WIRE)-- #Alzheimers--Data on Neurodon's drug candidates shows curative potential for diabetes, Parkinson's and Alzheimer's by targeting ER stress and calcium imbalance.Neurodon Announces Initiation of Investigational New Drug (IND)-Enabling Studies for NDC-0009, a Novel Small Molecule for the Treatment of Type 1 Diabetes (T1D)
CROWN POINT, Ind.--(BUSINESS WIRE)--Neurodon Corporation today announced the initiation of essential studies necessary to enable preparation of an Investigational New Drug (IND) application for the U.S. Food and Drug Administration (FDA) for NDC-0009, a novel molecule to treat T1D. Neurodon aims to initiate clinical trials in the second half of 2022. “We are excited to achieve this milestone with the selection of a development candidate for our diabetes program. Our molecules have demonstrated
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurodon
Sign Up For FreeTo access detailed company insights
Neurodon is focused on revolutionizing medicine by targeting cellular stress, which is a root cause of various diseases. The company develops disease-modifying therapeutics aimed at normalizing calcium transport in cells, specifically through the activation of the SERCA enzyme. Their research addresses conditions such as diabetes, Alzheimer's, Park... Read More
